<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="2.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Nutr.</journal-id>
<journal-title>Frontiers in Nutrition</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Nutr.</abbrev-journal-title>
<issn pub-type="epub">2296-861X</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fnut.2024.1506477</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Nutrition</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Positive association between advanced lung cancer inflammation index and gallstones, with greater impact on women: a cross-sectional study of the NHANES database</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" equal-contrib="yes">
<name><surname>Liu</surname> <given-names>Bailiang</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="author-notes" rid="fn0001"><sup>&#x2020;</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/2860231/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/software/"/>
</contrib>
<contrib contrib-type="author" equal-contrib="yes">
<name><surname>Jin</surname> <given-names>Luyuan</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="author-notes" rid="fn0001"><sup>&#x2020;</sup></xref>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/software/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Nan</surname> <given-names>Boyuan</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/2567586/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/software/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Sun</surname> <given-names>Zhongyi</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Chen</surname> <given-names>Fengyang</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<role content-type="https://credit.niso.org/contributor-roles/software/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Zhou</surname> <given-names>Yinghui</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/2195849/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Sa</surname> <given-names>Qila</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/2824150/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Feng</surname> <given-names>Yingnan</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<role content-type="https://credit.niso.org/contributor-roles/resources/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Men</surname> <given-names>Ao</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Wang</surname> <given-names>Wenxin</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Feng</surname> <given-names>Xiaodong</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="corresp" rid="c002"><sup>&#x002A;</sup></xref>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Zhang</surname> <given-names>Wei</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="corresp" rid="c001"><sup>&#x002A;</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/1831243/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
</contrib-group>
<aff id="aff1"><sup>1</sup><institution>Department of Hepatobiliary Surgery, General Hospital of Northern Theater Command</institution>, <addr-line>Shenyang</addr-line>, <country>China</country></aff>
<aff id="aff2"><sup>2</sup><institution>Postgraduate College, Dalian Medical University</institution>, <addr-line>Dalian</addr-line>, <country>China</country></aff>
<author-notes>
<fn fn-type="edited-by" id="fn0002">
<p>Edited by: Francesk Mulita, General Hospital of Eastern Achaia-Unit of Aigio, Greece</p>
</fn>
<fn fn-type="edited-by" id="fn0003">
<p>Reviewed by: Dimitrios Kehagias, University of Patras, Greece</p>
<p>Andreas Antzoulas, General University Hospital of Patras, Greece</p>
</fn>
<corresp id="c001">&#x002A;Correspondence: Wei Zhang, <email>zhang_wei_1980@163.com</email></corresp>
<corresp id="c002">Xiaodong Feng, <email>981613149@qq.com</email></corresp>
<fn fn-type="equal" id="fn0001"><p><sup>&#x2020;</sup>These authors have contributed equally to this work</p></fn>
</author-notes>
<pub-date pub-type="epub">
<day>20</day>
<month>12</month>
<year>2024</year>
</pub-date>
<pub-date pub-type="collection">
<year>2024</year>
</pub-date>
<volume>11</volume>
<elocation-id>1506477</elocation-id>
<history>
<date date-type="received">
<day>05</day>
<month>10</month>
<year>2024</year>
</date>
<date date-type="accepted">
<day>12</day>
<month>12</month>
<year>2024</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#x00A9; 2024 Liu, Jin, Nan, Sun, Chen, Zhou, Sa, Feng, Men, Wang, Feng and Zhang.</copyright-statement>
<copyright-year>2024</copyright-year>
<copyright-holder>Liu, Jin, Nan, Sun, Chen, Zhou, Sa, Feng, Men, Wang, Feng and Zhang</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<sec id="sec1">
<title>Background</title>
<p>Previous studies have shown that inflammation is crucial in gallstone formation. The Advanced Lung Cancer Inflammation Index (ALI) is a comprehensive measure that reflects inflammation and nutritional condition. However, there are no studies examining the relationship between ALI and gallstones. This study aimed to analyze this association in US adults.</p>
</sec>
<sec id="sec2">
<title>Methods</title>
<p>This study used a cross-sectional research design with in-depth analyses using data from the National Health and Nutrition Examination Survey (NHANES). The association between gallstones and ALI was systematically assessed by logistic regression analysis, subgroup analysis, basic participant characteristics, and smooth curve fits.</p>
</sec>
<sec id="sec3">
<title>Results</title>
<p>5,646 people participated in the study. ALI was converted into Quartile 1 (&#x2212;1.47&#x2013;1.00), Quartile 2 (1.00&#x2013;1.34), Quartile 3 (1.34&#x2013;1.69), and Quartile 4 (1.69&#x2013;4.38). In the fully adjusted model, gallstone prevalence increased by 45% in participants in the highest quartile compared to those in the lowest quartile (OR&#x202F;=&#x202F;1.45; 95% CI: 1.12&#x2013;1.87; <italic>p</italic>&#x202F;=&#x202F;0.005), and ALI was positively correlated with gallstones (OR&#x202F;=&#x202F;1.22; 95% CI: 1.03&#x2013;1.45; <italic>p</italic>&#x202F;=&#x202F;0.0232). Smooth curve fits provided evidence in favor of this finding. Significant gender differences were found in the relationship between gallstones and ALI by subgroup analysis (OR&#x202F;=&#x202F;1.43; 95% CI: 1.16&#x2013;1.76; <italic>p</italic> for interaction&#x202F;=&#x202F;0.0204).</p>
</sec>
<sec id="sec4">
<title>Conclusion</title>
<p>The study concluded that ALI and gallstones had a positive correlation, with ALI having a higher effect on women&#x2019;s gallstone prevalence.</p>
</sec>
</abstract>
<kwd-group>
<kwd>advanced lung cancer inflammation index</kwd>
<kwd>gallstones</kwd>
<kwd>NHANES</kwd>
<kwd>inflammation</kwd>
<kwd>nutrition</kwd>
<kwd>cross-sectional study</kwd>
</kwd-group>
<counts>
<fig-count count="2"/>
<table-count count="3"/>
<equation-count count="0"/>
<ref-count count="33"/>
<page-count count="8"/>
<word-count count="4777"/>
</counts>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-at-acceptance</meta-name>
<meta-value>Nutritional Epidemiology</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<sec sec-type="intro" id="sec5">
<label>1</label>
<title>Introduction</title>
<p>Gallstone disease is a common digestive system disorder and has become an important issue in modern healthcare. With an annual incidence of 0.60&#x2013;1.3% (<xref ref-type="bibr" rid="ref1">1</xref>), the prevalence of gallstones in US adults hovers around 10&#x2013;20%, and this number is increasing (<xref ref-type="bibr" rid="ref2">2</xref>). Although gallstones are usually asymptomatic, they can still be harmful. More than 20% of gallstone patients eventually experience common symptoms including colic or infection (<xref ref-type="bibr" rid="ref3">3</xref>). A few patients may even develop rare complications such as gallstone ileus, Mirizzi syndrome, and Bouveret syndrome (<xref ref-type="bibr" rid="ref4">4</xref>, <xref ref-type="bibr" rid="ref5">5</xref>). These symptoms cause great discomfort to the patient and impose an enormous financial strain on society and families. Therefore, gallstones are considered a severe public health concern that deserves vigilant attention from the medical community.</p>
<p>It is generally recognized that inflammation contributes significantly to the many factors that lead to gallstone development (<xref ref-type="bibr" rid="ref6 ref7 ref8">6&#x2013;8</xref>). Several inflammatory markers have been identified as potential indicators of the promotion of gallstone formation. C reactive protein and high-sensitivity C reactive protein, indicators of systemic inflammation, have been linked to an elevated risk of gallstone disease (<xref ref-type="bibr" rid="ref9">9</xref>, <xref ref-type="bibr" rid="ref10">10</xref>). Interleukin (IL)-6, a kind of cytokine, has been linked to gallstone formation due to its role in promoting inflammation (<xref ref-type="bibr" rid="ref8">8</xref>). Additionally, there is clear evidence linking the systemic immune-inflammatory index to a significant increase in gallstone prevalence (<xref ref-type="bibr" rid="ref11">11</xref>).</p>
<p>Integrating BMI, albumin, and neutrophil to lymphocyte ratio (NLR), the advanced lung cancer inflammation index (ALI) is a systemic inflammatory index. ALI was initially evaluated for lung cancer patients (<xref ref-type="bibr" rid="ref12">12</xref>). Given the value of the inflammatory aspects of the ALI assessment, several studies have explored its role in hypertension, diabetes, heart failure, rheumatoid arthritis, coronary artery disease, and stroke (<xref ref-type="bibr" rid="ref13 ref14 ref15 ref16 ref17 ref18">13&#x2013;18</xref>). Although inflammation is known to be linked to gallstones, it is unclear how ALI and gallstones are related.</p>
<p>Therefore, we aimed to use National Health and Nutrition Examination Survey (NHANES) to explore the association between ALI and gallstones among US adults.</p>
</sec>
<sec sec-type="materials|methods" id="sec6">
<label>2</label>
<title>Materials and methods</title>
<sec id="sec7">
<label>2.1</label>
<title>Study population</title>
<p>NHANES is a crucial resource offering extensive health and nutrition data from a nationally representative sample of the US population. It covers a wide array of health indicators and diseases through interviews and physical examinations, enabling researchers to identify risk factors, prevalence rates, and trends in public health. This comprehensive dataset supports epidemiological research and informs public health policy decisions, making it an invaluable tool for understanding the health status of Americans.</p>
<p>We used NHANES data from 2017 through March 2020 for our analysis. There were initially 15,560 participants, of which 6,328 participants younger than 20 were excluded. Participants lacking information about gallstones were excluded (<italic>n</italic>&#x202F;=&#x202F;20). Participants lacking ALI were excluded (<italic>n</italic>&#x202F;=&#x202F;2,476). Additionally, participants lacking data on covariates were excluded [total, <italic>n</italic>&#x202F;=&#x202F;2088; including education level, <italic>n</italic>&#x202F;=&#x202F;9; marital status, <italic>n</italic>&#x202F;=&#x202F;5; alcohol consumption, <italic>n</italic>&#x202F;=&#x202F;1,074; smoking status, <italic>n</italic>&#x202F;=&#x202F;4; diabetes, <italic>n</italic>&#x202F;=&#x202F;201; hypertension, <italic>n</italic>&#x202F;=&#x202F;7; poverty-to-income ratio (PIR), <italic>n</italic>&#x202F;=&#x202F;788]. In the end, there were 5,646 individuals in total for the research (<xref ref-type="fig" rid="fig1">Figure 1</xref>).</p>
<fig position="float" id="fig1">
<label>Figure 1</label>
<caption>
<p>Sample selection criteria flowchart.</p>
</caption>
<graphic xlink:href="fnut-11-1506477-g001.tif"/>
</fig>
</sec>
<sec id="sec8">
<label>2.2</label>
<title>Definition of gallstones</title>
<p>Based on the answers to the question &#x201C;Has DR ever said you have gallstones?&#x201D; we were able to assess whether or not the individuals had gallstones. Gallstones were classified as present in those who answered &#x201C;yes,&#x201D; whereas they were not in those who answered &#x201C;no&#x201D;.</p>
</sec>
<sec id="sec9">
<label>2.3</label>
<title>Measurement of ALI</title>
<p>ALI was computed using the formula BMI (kg/m<sup>2</sup>)&#x002A;albumin level (g/dL)/NLR. NLR was computed by dividing neutrophil counts by lymphocyte counts.</p>
</sec>
<sec id="sec10">
<label>2.4</label>
<title>Covariables</title>
<p>Our investigation took into account additional confounding factors that could alter the relationship between ALI and gallstones. Based on previously published literature (<xref ref-type="bibr" rid="ref11">11</xref>, <xref ref-type="bibr" rid="ref19 ref20 ref21">19&#x2013;21</xref>), the covariates chosen were age, gender, race, educational level, PIR, marital status (cohabitation/solitude), alcohol consumption, smoking status, diabetes, hypertension, BMI, albumin, neutrophil counts, and lymphocyte counts. Cohabitation in marital status included married and living with partner, and solitude included widowed, divorced, separated, and never married. Those who had ever smoked 100 cigarettes or more were considered smokers. Drinkers were those participants who consumed alcohol at least once a month. Diabetes status was determined by participants&#x2019; answers to the question &#x201C;Doctor told you have diabetes&#x201D;; and a similar questionnaire was used to identify hypertension.</p>
</sec>
<sec id="sec11">
<label>2.5</label>
<title>Statistical analysis</title>
<p>The study was statistically analyzed using R (version 3.4.3) and EmpowerStats (version 2.0). Statistical significance is indicated by a <italic>p</italic> value of less than 0.05. Two groups of participants were created based on whether or not gallstones were present. The ALI was subjected to a ln transformation because of its skewed distribution, which was then analyzed as a continuous variable. Four groups of participants were formed based on the quartiles of the ALI. Continuous variables were tested using Student&#x2019;s t-test and categorical variables using chi-square test. In three distinct models, multivariate logistic regression methods were utilized in the investigation of the association between the prevalence of gallstones and ALI. No covariates were adjusted in model 1. Age, race, and gender were adjusted in model 2. Model 3 took into account factors such as gender, age, race, education level, PIR, marital status, alcohol consumption, smoking, diabetes, and hypertension. Subgroup analysis were conducted using logistic regression models. Furthermore, we evaluated the nonlinear relationship between the prevalence of gallstones and ALI using smooth curve fits.</p>
</sec>
</sec>
<sec sec-type="results" id="sec12">
<label>3</label>
<title>Results</title>
<sec id="sec13">
<label>3.1</label>
<title>Baseline characteristics</title>
<p>The 5,646 individuals&#x2019; initial characteristics are displayed in <xref ref-type="table" rid="tab1">Table 1</xref>. The average age was 50.43&#x202F;&#x00B1;&#x202F;17.33&#x202F;years, with 50.21% male and 49.79% female individuals. The prevalence of gallstones was 10.63%. There were significant differences between the groups with and without gallstones in age, gender, race, alcohol consumption, smoking status, diabetes, hypertension, BMI, albumin, neutrophil counts, and lymphocyte counts. However, ALI between gallstone formers and non-gallstone formers was not significantly different (<italic>p</italic>&#x202F;=&#x202F;0.5080). Compared to non-gallstones participants, gallstone participants were more likely to be older, female, predominantly other Hispanic, smokers, non-drinkers, and to have diabetes, hypertension, higher BMI, higher albumin levels, higher neutrophil counts, and higher lymphocyte counts.</p>
<table-wrap position="float" id="tab1">
<label>Table 1</label>
<caption>
<p>Baseline characteristics of participants.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" valign="top">Characteristics</th>
<th align="center" valign="top">Non-stone formers (<italic>n</italic> =&#x202F;5,046)</th>
<th align="center" valign="top">Stone formers (<italic>n</italic> =&#x202F;600)</th>
<th align="center" valign="top"><italic>p</italic>-value</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" valign="top">Age (years)</td>
<td align="center" valign="top">49.58&#x202F;&#x00B1;&#x202F;17.35</td>
<td align="center" valign="top">57.53&#x202F;&#x00B1;&#x202F;15.49</td>
<td align="center" valign="top">&#x003C;0.001</td>
</tr>
<tr>
<td align="left" valign="top">Gender, <italic>n</italic> (%)</td>
<td/>
<td/>
<td align="center" valign="top">&#x003C;0.001</td>
</tr>
<tr>
<td align="left" valign="top">Male</td>
<td align="center" valign="top">2,663 (52.77)</td>
<td align="center" valign="top">172 (28.67)</td>
<td/>
</tr>
<tr>
<td align="left" valign="top">Female</td>
<td align="center" valign="top">2,383 (47.23)</td>
<td align="center" valign="top">428 (71.33)</td>
<td/>
</tr>
<tr>
<td align="left" valign="top">Race, <italic>n</italic> (%)</td>
<td/>
<td/>
<td align="center" valign="top">&#x003C;0.001</td>
</tr>
<tr>
<td align="left" valign="top">Mexican American</td>
<td align="center" valign="top">585 (11.59)</td>
<td align="center" valign="top">82 (13.67)</td>
<td/>
</tr>
<tr>
<td align="left" valign="top">Other Hispanic</td>
<td align="center" valign="top">481 (9.53)</td>
<td align="center" valign="top">69 (11.50)</td>
<td/>
</tr>
<tr>
<td align="left" valign="top">Non-Hispanic White</td>
<td align="center" valign="top">1956 (38.76)</td>
<td align="center" valign="top">275 (45.83)</td>
<td/>
</tr>
<tr>
<td align="left" valign="top">Non-Hispanic Black</td>
<td align="center" valign="top">1,296 (25.68)</td>
<td align="center" valign="top">107 (17.83)</td>
<td/>
</tr>
<tr>
<td align="left" valign="top">Other race</td>
<td align="center" valign="top">728 (14.43)</td>
<td align="center" valign="top">67 (11.17)</td>
<td/>
</tr>
<tr>
<td align="left" valign="top">Education level, <italic>n</italic> (%)</td>
<td/>
<td/>
<td align="center" valign="top">0.505</td>
</tr>
<tr>
<td align="left" valign="top">Less than high school</td>
<td align="center" valign="top">786 (15.58)</td>
<td align="center" valign="top">101 (16.83)</td>
<td/>
</tr>
<tr>
<td align="left" valign="top">High school or GED</td>
<td align="center" valign="top">1,211 (24.00)</td>
<td align="center" valign="top">151 (25.17)</td>
<td/>
</tr>
<tr>
<td align="left" valign="top">More than high school</td>
<td align="center" valign="top">3,049 (60.42)</td>
<td align="center" valign="top">348 (58.00)</td>
<td/>
</tr>
<tr>
<td align="left" valign="top">PIR</td>
<td align="center" valign="top">2.66&#x202F;&#x00B1;&#x202F;1.63</td>
<td align="center" valign="top">2.61&#x202F;&#x00B1;&#x202F;1.58</td>
<td align="center" valign="top">0.429</td>
</tr>
<tr>
<td align="left" valign="top">Marital status, <italic>n</italic> (%)</td>
<td/>
<td/>
<td align="center" valign="top">0.098</td>
</tr>
<tr>
<td align="left" valign="top">Cohabitation</td>
<td align="center" valign="top">2,934 (58.15)</td>
<td align="center" valign="top">370 (61.67)</td>
<td/>
</tr>
<tr>
<td align="left" valign="top">Solitude</td>
<td align="center" valign="top">2,112 (41.85)</td>
<td align="center" valign="top">230 (38.33)</td>
<td/>
</tr>
<tr>
<td align="left" valign="top">Alcohol consumption, <italic>n</italic> (%)</td>
<td/>
<td/>
<td align="center" valign="top">&#x003C;0.001</td>
</tr>
<tr>
<td align="left" valign="top">Yes</td>
<td align="center" valign="top">2,703 (53.57)</td>
<td align="center" valign="top">238 (39.67)</td>
<td/>
</tr>
<tr>
<td align="left" valign="top">No</td>
<td align="center" valign="top">2,343 (46.43)</td>
<td align="center" valign="top">362 (60.33)</td>
<td/>
</tr>
<tr>
<td align="left" valign="top">Smoking status, <italic>n</italic> (%)</td>
<td/>
<td/>
<td align="center" valign="top">0.001</td>
</tr>
<tr>
<td align="left" valign="top">Yes</td>
<td align="center" valign="top">2,259 (44.77)</td>
<td align="center" valign="top">311 (51.83)</td>
<td/>
</tr>
<tr>
<td align="left" valign="top">No</td>
<td align="center" valign="top">2,787 (55.23)</td>
<td align="center" valign="top">289 (48.17)</td>
<td/>
</tr>
<tr>
<td align="left" valign="top">Diabetes, <italic>n</italic> (%)</td>
<td/>
<td/>
<td align="center" valign="top">&#x003C;0.001</td>
</tr>
<tr>
<td align="left" valign="top">Yes</td>
<td align="center" valign="top">720 (14.27)</td>
<td align="center" valign="top">161 (26.83)</td>
<td/>
</tr>
<tr>
<td align="left" valign="top">No</td>
<td align="center" valign="top">4,326 (85.73)</td>
<td align="center" valign="top">439 (73.17)</td>
<td/>
</tr>
<tr>
<td align="left" valign="top">Hypertension, <italic>n</italic> (%)</td>
<td/>
<td/>
<td align="center" valign="top">&#x003C;0.001</td>
</tr>
<tr>
<td align="left" valign="top">Yes</td>
<td align="center" valign="top">1816 (35.99)</td>
<td align="center" valign="top">318 (53.00)</td>
<td/>
</tr>
<tr>
<td align="left" valign="top">No</td>
<td align="center" valign="top">3,230 (64.01)</td>
<td align="center" valign="top">282 (47.00)</td>
<td/>
</tr>
<tr>
<td align="left" valign="top">ALI</td>
<td align="center" valign="top">72.36&#x202F;&#x00B1;&#x202F;46.51</td>
<td align="center" valign="top">73.76&#x202F;&#x00B1;&#x202F;64.40</td>
<td align="center" valign="top">0.508</td>
</tr>
<tr>
<td align="left" valign="top">BMI (kg/m<sup>2</sup>)</td>
<td align="center" valign="top">29.82&#x202F;&#x00B1;&#x202F;7.38</td>
<td align="center" valign="top">33.46&#x202F;&#x00B1;&#x202F;8.47</td>
<td align="center" valign="top">&#x003C;0.001</td>
</tr>
<tr>
<td align="left" valign="top">Albumin (g/dL)</td>
<td align="center" valign="top">4.07&#x202F;&#x00B1;&#x202F;0.34</td>
<td align="center" valign="top">3.95&#x202F;&#x00B1;&#x202F;0.35</td>
<td align="center" valign="top">&#x003C;0.001</td>
</tr>
<tr>
<td align="left" valign="top">Neutrophil counts (K/uL)</td>
<td align="center" valign="top">4.17&#x202F;&#x00B1;&#x202F;1.69</td>
<td align="center" valign="top">4.48&#x202F;&#x00B1;&#x202F;2.03</td>
<td align="center" valign="top">&#x003C;0.001</td>
</tr>
<tr>
<td align="left" valign="top">Lymphocyte counts (K/uL)</td>
<td align="center" valign="top">2.20&#x202F;&#x00B1;&#x202F;1.36</td>
<td align="center" valign="top">2.78&#x202F;&#x00B1;&#x202F;14.58</td>
<td align="center" valign="top">0.007</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<p>The mean&#x202F;&#x00B1;&#x202F;standard deviation (SD) was used to record continuous variables. Frequencies or percentages was used to express categorical variables. ALI, advanced lung cancer inflammation index; BMI, body mass index; PIR, poverty-to-income ratio; GED, general educational development.</p>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="sec14">
<label>3.2</label>
<title>Association between ALI and gallstones</title>
<p><xref ref-type="table" rid="tab2">Table 2</xref> shows the association between ln-transformed ALI and gallstones. No correlation between ALI and gallstones was found in Model 1, which was not adjusted for confounding factors. However, after adjusting for confounding factors, a positive correlation between ALI and the prevalence of gallstones was detected in both Model 2 and Model 3. In Model 3, there was a 22% rise in gallstone prevalence for every unit rise in ln-transformed ALI (OR&#x202F;=&#x202F;1.22; 95% CI: 1.03&#x2013;1.45; <italic>p</italic>&#x202F;=&#x202F;0.0232). We calculated a cut-off value of 4.39 for ln-transformed ALI, above which the risk of developing gallstones increases. Then we convert the continuous ln-transformed ALI to Quartile 1 (&#x2212;1.47&#x2013;1.00), Quartile 2 (1.00&#x2013;1.34), Quartile 3 (1.34&#x2013;1.69), and Quartile 4 (1.69&#x2013;4.38). We still get the same results after converting ALI to quartiles for analysis. Gallstone prevalence was 45% higher in Quartile 4 participants than it was in Quartile 1 participants (OR&#x202F;=&#x202F;1.45; 95% CI: 1.12&#x2013;1.87; <italic>p</italic>&#x202F;=&#x202F;0.005). The <italic>p</italic> for trend analysis similarly supports the above findings in Model 2 (<italic>p</italic>&#x202F;=&#x202F;0.0046) and Model 3 (<italic>p</italic>&#x202F;=&#x202F;0.01). The results of the smooth curve fits provided additional evidence for the positive association between gallstones prevalence and ALI (<xref ref-type="fig" rid="fig2">Figure 2</xref>).</p>
<table-wrap position="float" id="tab2">
<label>Table 2</label>
<caption>
<p>The association between ln-transformed ALI and gallstones.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" valign="top" rowspan="2">Characteristic</th>
<th align="center" valign="top" colspan="3">OR (95% CI), <italic>p</italic> value</th>
</tr>
<tr>
<th align="center" valign="top">Model 1</th>
<th align="center" valign="top">Model 2</th>
<th align="center" valign="top">Model 3</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" valign="top">Ln-transformed ALI (continuous)</td>
<td align="center" valign="top">1.03 (0.88, 1.21) 0.7241</td>
<td align="center" valign="top">1.23 (1.04, 1.46) 0.0161</td>
<td align="center" valign="top">1.22 (1.03, 1.45) 0.0232</td>
</tr>
<tr>
<td align="left" valign="top" colspan="4">Ln-transformed ALI (quartile)</td>
</tr>
<tr>
<td align="left" valign="top">Quartile 1 (&#x2212;1.47&#x2013;1.00)</td>
<td align="center" valign="top">Reference</td>
<td align="center" valign="top">Reference</td>
<td align="center" valign="top">Reference</td>
</tr>
<tr>
<td align="left" valign="top">Quartile 2 (1.00&#x2013;1.34)</td>
<td align="center" valign="top">1.07 (0.84, 1.36) 0.5776</td>
<td align="center" valign="top">1.21 (0.95, 1.56) 0.1246</td>
<td align="center" valign="top">1.21 (0.94, 1.56) 0.1329</td>
</tr>
<tr>
<td align="left" valign="top">Quartile 3 (1.34&#x2013;1.69)</td>
<td align="center" valign="top">0.96 (0.75, 1.23) 0.7596</td>
<td align="center" valign="top">1.15 (0.89, 1.49) 0.2746</td>
<td align="center" valign="top">1.14 (0.88, 1.48) 0.3113</td>
</tr>
<tr>
<td align="left" valign="top">Quartile 4 (1.69&#x2013;4.38)</td>
<td align="center" valign="top">1.12 (0.89, 1.43) 0.3329</td>
<td align="center" valign="top">1.49 (1.15, 1.92) 0.0022</td>
<td align="center" valign="top">1.45 (1.12, 1.87) 0.0050</td>
</tr>
<tr>
<td align="left" valign="top">P for trend</td>
<td align="center" valign="top">0.4762</td>
<td align="center" valign="top">0.0046</td>
<td align="center" valign="top">0.0100</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<p>In sensitivity analysis, ln-transformed ALI was converted from a continuous variable to a categorical variable (quartiles). ALI, advanced lung cancer inflammation index; OR, odds ratio; 95% CI, 95% confidence interval. Model 1: no covariates were adjusted. Model 2: age, gender, and race were adjusted. Model 3: age, gender, race, educational level, poverty-to-income ratio, marital status, alcohol consumption, smoking status, diabetes, and hypertension were adjusted.</p>
</table-wrap-foot>
</table-wrap>
<fig position="float" id="fig2">
<label>Figure 2</label>
<caption>
<p>Linear relationship between ln-transformed ALI and gallstones.</p>
</caption>
<graphic xlink:href="fnut-11-1506477-g002.tif"/>
</fig>
</sec>
<sec id="sec15">
<label>3.3</label>
<title>Subgroup analysis</title>
<p>We used subgroup analysis and interaction tests to detect the association between ALI and gallstones in different subgroups. Gender, race, education level, marital status, alcohol consumption, smoking, diabetes, and hypertension were included in subgroup analysis as stratification factors (<xref ref-type="table" rid="tab3">Table 3</xref>). The subgroup analysis&#x2019;s findings demonstrated that, except for gender, none of the other stratification factors significantly interacted with the ALI and gallstones (p for interaction&#x003E;0.05). Significant gender differences in the association between ALI and gallstones. A higher ALI was more strongly linked to women&#x2019;s gallstone prevalence (OR&#x202F;=&#x202F;1.43; 95% CI: 1.16&#x2013;1.76; <italic>p</italic> for interaction&#x202F;=&#x202F;0.0204). Thus, the alterations in the ALI had a greater impact on women&#x2019;s gallstone prevalence.</p>
<table-wrap position="float" id="tab3">
<label>Table 3</label>
<caption>
<p>Association between ln-transformed ALI and gallstones in subgroups.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" valign="top">Subgroup</th>
<th align="center" valign="top">OR (95% CI)</th>
<th align="center" valign="top"><italic>p</italic> value</th>
<th align="center" valign="top">P for interaction</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" valign="top">Gender</td>
<td/>
<td/>
<td align="center" valign="top">0.0204</td>
</tr>
<tr>
<td align="left" valign="top">Male</td>
<td align="center" valign="top">0.93 (0.69, 1.26)</td>
<td align="center" valign="top">0.6583</td>
<td/>
</tr>
<tr>
<td align="left" valign="top">Female</td>
<td align="center" valign="top">1.43 (1.16, 1.76)</td>
<td align="center" valign="top">0.0007</td>
<td/>
</tr>
<tr>
<td align="left" valign="top">Race</td>
<td/>
<td/>
<td align="center" valign="top">0.7734</td>
</tr>
<tr>
<td align="left" valign="top">Mexican American</td>
<td align="center" valign="top">1.15 (0.69, 1.94)</td>
<td align="center" valign="top">0.5924</td>
<td/>
</tr>
<tr>
<td align="left" valign="top">Other Hispanic</td>
<td align="center" valign="top">1.17 (0.68, 2.02)</td>
<td align="center" valign="top">0.5626</td>
<td/>
</tr>
<tr>
<td align="left" valign="top">Non-Hispanic White</td>
<td align="center" valign="top">1.27 (0.98, 1.64)</td>
<td align="center" valign="top">0.0655</td>
<td/>
</tr>
<tr>
<td align="left" valign="top">Non-Hispanic Black</td>
<td align="center" valign="top">0.99 (0.69, 1.43)</td>
<td align="center" valign="top">0.9753</td>
<td/>
</tr>
<tr>
<td align="left" valign="top">Other Race</td>
<td align="center" valign="top">1.46 (0.87, 2.47)</td>
<td align="center" valign="top">0.1560</td>
<td/>
</tr>
<tr>
<td align="left" valign="top">Education level</td>
<td/>
<td/>
<td align="center" valign="top">0.3527</td>
</tr>
<tr>
<td align="left" valign="top">Less than high school</td>
<td align="center" valign="top">0.91 (0.60, 1.40)</td>
<td align="center" valign="top">0.6722</td>
<td/>
</tr>
<tr>
<td align="left" valign="top">High school or GED</td>
<td align="center" valign="top">1.30 (0.91, 1.86)</td>
<td align="center" valign="top">0.1435</td>
<td/>
</tr>
<tr>
<td align="left" valign="top">More than high school</td>
<td align="center" valign="top">1.28 (1.02, 1.59)</td>
<td align="center" valign="top">0.0308</td>
<td/>
</tr>
<tr>
<td align="left" valign="top">Marital status</td>
<td/>
<td/>
<td align="center" valign="top">0.1504</td>
</tr>
<tr>
<td align="left" valign="top">Cohabitation</td>
<td align="center" valign="top">1.22 (0.98, 1.52)</td>
<td align="center" valign="top">0.0694</td>
<td/>
</tr>
<tr>
<td align="left" valign="top">Solitude</td>
<td align="center" valign="top">1.21 (0.93, 1.58)</td>
<td align="center" valign="top">0.1504</td>
<td/>
</tr>
<tr>
<td align="left" valign="top">Alcohol consumption</td>
<td/>
<td/>
<td align="center" valign="top">0.7484</td>
</tr>
<tr>
<td align="left" valign="top">Yes</td>
<td align="center" valign="top">1.20 (0.96, 1.49)</td>
<td align="center" valign="top">0.1053</td>
<td/>
</tr>
<tr>
<td align="left" valign="top">No</td>
<td align="center" valign="top">1.27 (0.96, 1.67)</td>
<td align="center" valign="top">0.0912</td>
<td/>
</tr>
<tr>
<td align="left" valign="top">Smoking status</td>
<td/>
<td/>
<td align="center" valign="top">0.6832</td>
</tr>
<tr>
<td align="left" valign="top">Yes</td>
<td align="center" valign="top">1.17 (0.93, 1.48)</td>
<td align="center" valign="top">0.1896</td>
<td/>
</tr>
<tr>
<td align="left" valign="top">No</td>
<td align="center" valign="top">1.25 (0.98, 1.60)</td>
<td align="center" valign="top">0.0670</td>
<td/>
</tr>
<tr>
<td align="left" valign="top">Diabetes</td>
<td/>
<td/>
<td align="center" valign="top">0.6882</td>
</tr>
<tr>
<td align="left" valign="top">Yes</td>
<td align="center" valign="top">1.29 (0.92, 1.81)</td>
<td align="center" valign="top">0.1385</td>
<td/>
</tr>
<tr>
<td align="left" valign="top">No</td>
<td align="center" valign="top">1.19 (0.98, 1.45)</td>
<td align="center" valign="top">0.0808</td>
<td/>
</tr>
<tr>
<td align="left" valign="top">Hypertension</td>
<td/>
<td/>
<td align="center" valign="top">0.8488</td>
</tr>
<tr>
<td align="left" valign="top">Yes</td>
<td align="center" valign="top">1.22 (0.97, 1.54)</td>
<td align="center" valign="top">0.0921</td>
<td/>
</tr>
<tr>
<td align="left" valign="top">No</td>
<td align="center" valign="top">1.18 (0.92, 1.51)</td>
<td align="center" valign="top">0.1836</td>
<td/>
</tr>
</tbody>
</table>
<table-wrap-foot>
<p>The results of subgroup analysis were adjusted for all covariates except the effect modifier. OR, odds ratio; 95% CI, 95% confidence interval; GED, general educational development.</p>
</table-wrap-foot>
</table-wrap>
</sec>
</sec>
<sec sec-type="discussion" id="sec16">
<label>4</label>
<title>Discussion</title>
<p>The relationship between ALI and gallstones among US adults is being examined for the first time with our cross-sectional investigation. The results suggested that elevated ALI was significantly associated with a higher gallstone prevalence after further adjustment for potential confounding variables. The smooth curve fits result further demonstrated the positive correlation. Additionally, the association between gallstones and ALI varied significantly according to gender. The prevalence of gallstones is more likely to be affected by high ALI levels in female individuals.</p>
<p>The impact of inflammation on gallstones is receiving more and more widespread attention. In a cross-sectional investigation involving 4,950 US adult participants based on the NHANES database, Meng et al. discovered that a higher systemic immune-inflammatory index was independently linked to the probability of gallstone prevalence under 50 (<xref ref-type="bibr" rid="ref11">11</xref>). In a case&#x2013;control research including 150 Iranian women, Ghorbani et al. discovered a considerable positive correlation between the incidence of gallstones and high-sensitivity C reactive protein (<xref ref-type="bibr" rid="ref22">22</xref>). This is similar to our finding that the prevalence of gallstones in women is positively correlated with ALI levels. Pro-inflammatory diets can increase systemic levels of inflammation, and several studies have found that increased intake of pro-inflammatory foods is linked to an elevated risk of gallstones (<xref ref-type="bibr" rid="ref19">19</xref>, <xref ref-type="bibr" rid="ref22">22</xref>). High levels of circulating inflammatory proteins, such as IL-6, IL-10, IL-12 (p70), and IL-13, were linked to an elevated incidence of gallstones, according to a cross-sectional study by Liu et al. with 299 participants from Shanghai, China (<xref ref-type="bibr" rid="ref8">8</xref>). In a case&#x2013;control study, Hsing et al. found that variants in several genes influencing inflammatory responses were associated with gallstones (<xref ref-type="bibr" rid="ref23">23</xref>). Our research shows a correlation between high levels of ALI and higher gallstones prevalence, this agrees with the findings described above.</p>
<p>Gallstone development is influenced by environmental and genetic risk factors (<xref ref-type="bibr" rid="ref3">3</xref>, <xref ref-type="bibr" rid="ref24">24</xref>). Among these risk factors, inflammation and nutritional status have a substantial effect on gallstone formation. Albumin, as one of the indicators of nutritional status, was found to be statistically significant in our study in the difference between gallstone formers (3.95&#x202F;&#x00B1;&#x202F;0.35) and non-gallstone formers (4.07&#x202F;&#x00B1;&#x202F;0.34). However, the difference is not clinically significant in clinical practice. The ALI is obtained from BMI, albumin, and NLR calculations and is an all-encompassing representation of the body&#x2019;s nutritional and inflammatory conditions. Elevated BMI, one of the indicators used to assess obesity, is independently correlated with gallstone formation (<xref ref-type="bibr" rid="ref25">25</xref>, <xref ref-type="bibr" rid="ref26">26</xref>). Our study found that the mean BMI of gallstone formers was 33&#x202F;kg/m<sup>2</sup>, meaning they have obesity class I, which also supports the above conclusions. Obese state is an inflammatory state, which is also associated with gallstone formation. Obese patients usually have higher cholesterol and triglycerides (<xref ref-type="bibr" rid="ref27">27</xref>). In turn, higher cholesterol and triglyceride levels are associated with an increased risk of gallstone disease (<xref ref-type="bibr" rid="ref3">3</xref>). High levels of insulin in obese individuals can lead to increased cholesterol production by stimulating 3-hydroxy-3-methylglutaryl-coenzyme a reductase activity, which consequently raises gallstones risk (<xref ref-type="bibr" rid="ref28">28</xref>, <xref ref-type="bibr" rid="ref29">29</xref>). Immune cells and multiple kinds of inflammatory cytokines are involved in gallstone formation. One study carried out on immunodeficient mice demonstrated a noteworthy rise in gallstone occurrence after the transfer of T lymphocytes (<xref ref-type="bibr" rid="ref30">30</xref>). Neutrophils are more likely to trespass into the bile in an inflammatory state, and neutrophil extracellular traps formed by neutrophils and their extracellular DNA can promote gallstone formation by agglomerating calcium and cholesterol crystals (<xref ref-type="bibr" rid="ref31">31</xref>). Our study found a significant gender difference in ALI and gallstones, with a more significant association in women. This may be related to gender differences in immune function. Compared to men, women have higher levels of estrogen in their bodies. The number of neutrophils is higher in high estrogen populations (<xref ref-type="bibr" rid="ref32">32</xref>) and estrogens also modify cellular communication to enhance neutrophil activity (<xref ref-type="bibr" rid="ref33">33</xref>). In turn, increased neutrophils can further promote gallstone formation through pathways such as neutrophil extracellular traps (<xref ref-type="bibr" rid="ref31">31</xref>).</p>
<p>This study reveals a positive correlation between ALI and the prevalence of gallstones. Specifically, the prevalence of gallstones increased significantly when the ln-transformed ALI exceeded 4.39. This finding not only provides a new perspective for understanding the mechanism of gallstone formation, but also provides guidance for clinical practice. In clinical practice, special attention should be paid to screening and prevention of gallstones in patients with high ALI. Regular ultrasonography and other imaging tests are performed to aid in the early detection of gallstones, leading to timely intervention. We also found this relationship to be more pronounced in women. Therefore, in clinical practice, more attention should be paid to monitoring and controlling ALI in female patients, especially those with higher ALI, to reduce the risk of gallstones.</p>
<p>There are various advantages to this study. The relationship between ALI and gallstones is being examined for the first time in this study. The study is based on the NHANES database, which offers a more objective picture of the American people and has a bigger and more representative sample size. The study was adjusted for confounding covariates to guarantee more reliable findings. Additionally, in order to examine the strength of the correlation between gallstones and ALI in various groups, we conducted subgroup analyses. This study contains several restrictions. It was not possible to investigate a causal link between ALI and gallstones because the study was cross-sectional. Gallstone, diabetes, and hypertension diagnosis were based on questionnaires without objective exams, which made the diagnosis less objective. Although several covariates were considered in the study, we were unable to exclude the influence of all potential confounders such as genetics, hematological disorders, rapid weight loss, previous bypass surgeries, cholesterol, and triglycerides.</p>
</sec>
<sec sec-type="conclusions" id="sec17">
<label>5</label>
<title>Conclusion</title>
<p>In this study, we found that ALI was positively associated with gallstones and that ALI had a higher effect on women&#x2019;s gallstone prevalence. The findings suggest that early and effective management of ALI may reduce the prevalence of gallstones and have greater benefits for the female population. To validate the authors&#x2019; findings, larger prospective studies are still required.</p>
</sec>
</body>
<back>
<sec sec-type="data-availability" id="sec18">
<title>Data availability statement</title>
<p>Publicly available datasets were analyzed in this study. This data can be found here: <ext-link xlink:href="https://www.cdc.gov/nchs/nhanes/index.htm" ext-link-type="uri">https://www.cdc.gov/nchs/nhanes/index.htm</ext-link>.</p>
</sec>
<sec sec-type="ethics-statement" id="sec19">
<title>Ethics statement</title>
<p>The studies involving humans were approved by National Center for Health Statistics Institutional Review Board and Ethics Review Board. The studies were conducted in accordance with the local legislation and institutional requirements. The participants provided their written informed consent to participate in this study.</p>
</sec>
<sec sec-type="author-contributions" id="sec20">
<title>Author contributions</title>
<p>BL: Writing &#x2013; original draft, Conceptualization, Data curation, Formal analysis, Methodology, Software. LJ: Conceptualization, Methodology, Software, Writing &#x2013; original draft. BN: Methodology, Software, Writing &#x2013; original draft. ZS: Methodology, Writing &#x2013; original draft. FC: Software, Writing &#x2013; original draft. YZ: Writing &#x2013; original draft. QS: Methodology, Writing &#x2013; original draft. YF: Resources, Writing &#x2013; original draft. AM: Data curation, Writing &#x2013; original draft. WW: Data curation, Writing &#x2013; original draft. XF: Conceptualization, Data curation, Writing &#x2013; review &#x0026; editing. WZ: Conceptualization, Data curation, Writing &#x2013; review &#x0026; editing.</p>
</sec>
<sec sec-type="funding-information" id="sec21">
<title>Funding</title>
<p>The author(s) declare that no financial support was received for the research, authorship, and/or publication of this article.</p>
</sec>
<ack>
<p>We are grateful to each subject who participated in the study.</p>
</ack>
<sec sec-type="COI-statement" id="sec22">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec sec-type="ai-statement" id="sec23">
<title>Generative AI statement</title>
<p>The author(s) declare that no Gen AI was used in the creation of this manuscript.</p>
</sec>
<sec sec-type="disclaimer" id="sec24">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<ref-list>
<title>References</title>
<ref id="ref1"><label>1.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shabanzadeh</surname> <given-names>DM</given-names></name></person-group>. <article-title>Incidence of gallstone disease and complications</article-title>. <source>Curr Opin Gastroenterol</source>. (<year>2018</year>) <volume>34</volume>:<fpage>81</fpage>&#x2013;<lpage>9</lpage>. doi: <pub-id pub-id-type="doi">10.1097/mog.0000000000000418</pub-id>, PMID: <pub-id pub-id-type="pmid">29256915</pub-id></citation></ref>
<ref id="ref2"><label>2.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sheng</surname> <given-names>B</given-names></name> <name><surname>Zhao</surname> <given-names>Q</given-names></name> <name><surname>Ma</surname> <given-names>M</given-names></name> <name><surname>Zhang</surname> <given-names>J</given-names></name></person-group>. <article-title>An inverse association of weight and the occurrence of asymptomatic gallbladder stone disease in hypercholesterolemia patients: a case-control study</article-title>. <source>Lipids Health Dis</source>. (<year>2020</year>) <volume>19</volume>:<fpage>228</fpage>. doi: <pub-id pub-id-type="doi">10.1186/s12944-020-01402-8</pub-id>, PMID: <pub-id pub-id-type="pmid">33097057</pub-id></citation></ref>
<ref id="ref3"><label>3.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lammert</surname> <given-names>F</given-names></name> <name><surname>Gurusamy</surname> <given-names>K</given-names></name> <name><surname>Ko</surname> <given-names>CW</given-names></name> <name><surname>Miquel</surname> <given-names>JF</given-names></name> <name><surname>M&#x00E9;ndez-S&#x00E1;nchez</surname> <given-names>N</given-names></name> <name><surname>Portincasa</surname> <given-names>P</given-names></name> <etal/></person-group>. <article-title>Gallstones</article-title>. <source>Nat Rev Dis Prim</source>. (<year>2016</year>) <volume>2</volume>:<fpage>16024</fpage>. doi: <pub-id pub-id-type="doi">10.1038/nrdp.2016.24</pub-id></citation></ref>
<ref id="ref4"><label>4.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mulita</surname> <given-names>F</given-names></name> <name><surname>Tchabashvili</surname> <given-names>L</given-names></name> <name><surname>Bousis</surname> <given-names>D</given-names></name> <name><surname>Kehagias</surname> <given-names>D</given-names></name> <name><surname>Kaplanis</surname> <given-names>C</given-names></name> <name><surname>Liolis</surname> <given-names>E</given-names></name> <etal/></person-group>. <article-title>Gallstone ileus: a rare cause of small intestine obstruction</article-title>. <source>Clin Case Reports</source>. (<year>2021</year>) <volume>9</volume>:<fpage>e04924</fpage>. doi: <pub-id pub-id-type="doi">10.1002/ccr3.4924</pub-id>, PMID: <pub-id pub-id-type="pmid">34765198</pub-id></citation></ref>
<ref id="ref5"><label>5.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Alemi</surname> <given-names>F</given-names></name> <name><surname>Seiser</surname> <given-names>N</given-names></name> <name><surname>Ayloo</surname> <given-names>S</given-names></name></person-group>. <article-title>Gallstone disease: cholecystitis, Mirizzi syndrome, Bouveret syndrome, gallstone ileus</article-title>. <source>Surg Clin North Am</source>. (<year>2019</year>) <volume>99</volume>:<fpage>231</fpage>&#x2013;<lpage>44</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.suc.2018.12.006</pub-id>, PMID: <pub-id pub-id-type="pmid">30846032</pub-id></citation></ref>
<ref id="ref6"><label>6.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fremont-Rahl</surname> <given-names>JJ</given-names></name> <name><surname>Ge</surname> <given-names>Z</given-names></name> <name><surname>Umana</surname> <given-names>C</given-names></name> <name><surname>Whary</surname> <given-names>MT</given-names></name> <name><surname>Taylor</surname> <given-names>NS</given-names></name> <name><surname>Muthupalani</surname> <given-names>S</given-names></name> <etal/></person-group>. <article-title>An analysis of the role of the indigenous microbiota in cholesterol gallstone pathogenesis</article-title>. <source>PloS one</source>. (<year>2013</year>) <volume>8</volume>:<fpage>e70657</fpage>. doi: <pub-id pub-id-type="doi">10.1371/journal.pone.0070657</pub-id>, PMID: <pub-id pub-id-type="pmid">23923015</pub-id></citation></ref>
<ref id="ref7"><label>7.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shabanzadeh</surname> <given-names>DM</given-names></name> <name><surname>Skaaby</surname> <given-names>T</given-names></name> <name><surname>S&#x00F8;rensen</surname> <given-names>LT</given-names></name> <name><surname>Eugen-Olsen</surname> <given-names>J</given-names></name> <name><surname>J&#x00F8;rgensen</surname> <given-names>T</given-names></name></person-group>. <article-title>Metabolic biomarkers and gallstone disease&#x2014;a population-based study</article-title>. <source>Scand J Gastroenterol</source>. (<year>2017</year>) <volume>52</volume>:<fpage>1270</fpage>&#x2013;<lpage>7</lpage>. doi: <pub-id pub-id-type="doi">10.1080/00365521.2017.1365166</pub-id>, PMID: <pub-id pub-id-type="pmid">28799434</pub-id></citation></ref>
<ref id="ref8"><label>8.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname> <given-names>Z</given-names></name> <name><surname>Kemp</surname> <given-names>TJ</given-names></name> <name><surname>Gao</surname> <given-names>YT</given-names></name> <name><surname>Corbel</surname> <given-names>A</given-names></name> <name><surname>McGee</surname> <given-names>EE</given-names></name> <name><surname>Wang</surname> <given-names>B</given-names></name> <etal/></person-group>. <article-title>Association of circulating inflammation proteins and gallstone disease</article-title>. <source>J Gastroenterol Hepatol</source>. (<year>2018</year>) <volume>33</volume>:<fpage>1920</fpage>&#x2013;<lpage>4</lpage>. doi: <pub-id pub-id-type="doi">10.1111/jgh.14265</pub-id>, PMID: <pub-id pub-id-type="pmid">29671891</pub-id></citation></ref>
<ref id="ref9"><label>9.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname> <given-names>T</given-names></name> <name><surname>Siyin</surname> <given-names>ST</given-names></name> <name><surname>Yao</surname> <given-names>N</given-names></name> <name><surname>Duan</surname> <given-names>N</given-names></name> <name><surname>Xu</surname> <given-names>G</given-names></name> <name><surname>Li</surname> <given-names>W</given-names></name> <etal/></person-group>. <article-title>Relationship between high-sensitivity C reactive protein and the risk of gallstone disease: results from the Kailuan cohort study</article-title>. <source>BMJ Open</source>. (<year>2020</year>) <volume>10</volume>:<fpage>e035880</fpage>. doi: <pub-id pub-id-type="doi">10.1136/bmjopen-2019-035880</pub-id>, PMID: <pub-id pub-id-type="pmid">32963062</pub-id></citation></ref>
<ref id="ref10"><label>10.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Higashiyama</surname> <given-names>A</given-names></name> <name><surname>Wakabayashi</surname> <given-names>I</given-names></name> <name><surname>Kubota</surname> <given-names>Y</given-names></name> <name><surname>Adachi</surname> <given-names>Y</given-names></name> <name><surname>Hayashibe</surname> <given-names>A</given-names></name> <name><surname>Nishimura</surname> <given-names>K</given-names></name> <etal/></person-group>. <article-title>Does high-sensitivity C-reactive protein or low-density lipoprotein cholesterol show a stronger relationship with the cardio-ankle vascular index in healthy community dwellers?: the KOBE study</article-title>. <source>J Atheroscler Thromb</source>. (<year>2012</year>) <volume>19</volume>:<fpage>1027</fpage>&#x2013;<lpage>34</lpage>. doi: <pub-id pub-id-type="doi">10.5551/jat.13599</pub-id>, PMID: <pub-id pub-id-type="pmid">22785137</pub-id></citation></ref>
<ref id="ref11"><label>11.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Meng</surname> <given-names>C</given-names></name> <name><surname>Liu</surname> <given-names>K</given-names></name></person-group>. <article-title>Higher levels of systemic immune-inflammatory index are associated with the prevalence of gallstones in people under 50&#x202F;years of age in the United States: a cross-sectional analysis based on NHANES</article-title>. <source>Front Med</source>. (<year>2023</year>) <volume>10</volume>:<fpage>1320735</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fmed.2023.1320735</pub-id>, PMID: <pub-id pub-id-type="pmid">38283040</pub-id></citation></ref>
<ref id="ref12"><label>12.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mountzios</surname> <given-names>G</given-names></name> <name><surname>Samantas</surname> <given-names>E</given-names></name> <name><surname>Senghas</surname> <given-names>K</given-names></name> <name><surname>Zervas</surname> <given-names>E</given-names></name> <name><surname>Krisam</surname> <given-names>J</given-names></name> <name><surname>Samitas</surname> <given-names>K</given-names></name> <etal/></person-group>. <article-title>Association of the advanced lung cancer inflammation index (ALI) with immune checkpoint inhibitor efficacy in patients with advanced non-small-cell lung cancer</article-title>. <source>ESMO open</source>. (<year>2021</year>) <volume>6</volume>:<fpage>100254</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.esmoop.2021.100254</pub-id>, PMID: <pub-id pub-id-type="pmid">34481329</pub-id></citation></ref>
<ref id="ref13"><label>13.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tu</surname> <given-names>J</given-names></name> <name><surname>Wu</surname> <given-names>B</given-names></name> <name><surname>Xiu</surname> <given-names>J</given-names></name> <name><surname>Deng</surname> <given-names>J</given-names></name> <name><surname>Lin</surname> <given-names>S</given-names></name> <name><surname>Lu</surname> <given-names>J</given-names></name> <etal/></person-group>. <article-title>Advanced lung cancer inflammation index is associated with long-term cardiovascular death in hypertensive patients: national health and nutrition examination study, 1999-2018</article-title>. <source>Front Physiol</source>. (<year>2023</year>) <volume>14</volume>:<fpage>1074672</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fphys.2023.1074672</pub-id>, PMID: <pub-id pub-id-type="pmid">37206362</pub-id></citation></ref>
<ref id="ref14"><label>14.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname> <given-names>Y</given-names></name> <name><surname>Guan</surname> <given-names>M</given-names></name> <name><surname>Wang</surname> <given-names>R</given-names></name> <name><surname>Wang</surname> <given-names>X</given-names></name></person-group>. <article-title>Relationship between advanced lung cancer inflammation index and long-term all-cause, cardiovascular, and cancer mortality among type 2 diabetes mellitus patients: NHANES, 1999-2018</article-title>. <source>Front Endocrinol</source>. (<year>2023</year>) <volume>14</volume>:<fpage>1298345</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fendo.2023.1298345</pub-id>, PMID: <pub-id pub-id-type="pmid">38111710</pub-id></citation></ref>
<ref id="ref15"><label>15.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yuan</surname> <given-names>X</given-names></name> <name><surname>Huang</surname> <given-names>B</given-names></name> <name><surname>Wang</surname> <given-names>R</given-names></name> <name><surname>Tie</surname> <given-names>H</given-names></name> <name><surname>Luo</surname> <given-names>S</given-names></name></person-group>. <article-title>The prognostic value of advanced lung cancer inflammation index (ALI) in elderly patients with heart failure</article-title>. <source>Front Cardiovas Med</source>. (<year>2022</year>) <volume>9</volume>:<fpage>934551</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fcvm.2022.934551</pub-id>, PMID: <pub-id pub-id-type="pmid">36440019</pub-id></citation></ref>
<ref id="ref16"><label>16.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fan</surname> <given-names>W</given-names></name> <name><surname>Zhang</surname> <given-names>Y</given-names></name> <name><surname>Liu</surname> <given-names>Y</given-names></name> <name><surname>Ding</surname> <given-names>Z</given-names></name> <name><surname>Si</surname> <given-names>Y</given-names></name> <name><surname>Shi</surname> <given-names>F</given-names></name> <etal/></person-group>. <article-title>Nomograms based on the advanced lung Cancer inflammation index for the prediction of coronary artery disease and calcification</article-title>. <source>Clin Appl Thromb Hemost</source>. (<year>2021</year>) <volume>27</volume>:<fpage>10760296211060455</fpage>. doi: <pub-id pub-id-type="doi">10.1177/10760296211060455</pub-id>, PMID: <pub-id pub-id-type="pmid">34786986</pub-id></citation></ref>
<ref id="ref17"><label>17.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tian</surname> <given-names>X</given-names></name> <name><surname>Qu</surname> <given-names>Z</given-names></name> <name><surname>Sun</surname> <given-names>Y</given-names></name> <name><surname>Zhang</surname> <given-names>B</given-names></name></person-group>. <article-title>Association between the advanced lung cancer inflammation index and all-cause and cardiovascular mortality in patients with RA: insights from NHANES data analysis</article-title>. <source>Heliyon</source>. (<year>2024</year>) <volume>10</volume>:<fpage>e33673</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.heliyon.2024.e33673</pub-id>, PMID: <pub-id pub-id-type="pmid">39071694</pub-id></citation></ref>
<ref id="ref18"><label>18.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname> <given-names>X</given-names></name> <name><surname>Hong</surname> <given-names>C</given-names></name> <name><surname>Guo</surname> <given-names>Z</given-names></name> <name><surname>Huang</surname> <given-names>H</given-names></name> <name><surname>Ye</surname> <given-names>L</given-names></name></person-group>. <article-title>Association between advanced lung cancer inflammation index and all-cause and cardiovascular mortality among stroke patients: NHANES, 1999-2018</article-title>. <source>Front Public Health</source>. (<year>2024</year>) <volume>12</volume>:<fpage>1370322</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fpubh.2024.1370322</pub-id>, PMID: <pub-id pub-id-type="pmid">38699426</pub-id></citation></ref>
<ref id="ref19"><label>19.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cheng</surname> <given-names>J</given-names></name> <name><surname>Zhuang</surname> <given-names>Q</given-names></name> <name><surname>Wang</surname> <given-names>W</given-names></name> <name><surname>Li</surname> <given-names>J</given-names></name> <name><surname>Zhou</surname> <given-names>L</given-names></name> <name><surname>Xu</surname> <given-names>Y</given-names></name> <etal/></person-group>. <article-title>Association of pro-inflammatory diet with increased risk of gallstone disease: a cross-sectional study of NHANES January 2017-march 2020</article-title>. <source>Front Nutr</source>. (<year>2024</year>) <volume>11</volume>:<fpage>1344699</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fnut.2024.1344699</pub-id>, PMID: <pub-id pub-id-type="pmid">38549748</pub-id></citation></ref>
<ref id="ref20"><label>20.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname> <given-names>G</given-names></name> <name><surname>Ding</surname> <given-names>Z</given-names></name> <name><surname>Yang</surname> <given-names>J</given-names></name> <name><surname>Wang</surname> <given-names>T</given-names></name> <name><surname>Tong</surname> <given-names>L</given-names></name> <name><surname>Cheng</surname> <given-names>J</given-names></name> <etal/></person-group>. <article-title>Higher visceral adiposity index was associated with an elevated prevalence of gallstones and an earlier age at first gallstone surgery in US adults: the results are based on a cross-sectional study</article-title>. <source>Front Endocrinol</source>. (<year>2023</year>) <volume>14</volume>:<fpage>1189553</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fendo.2023.1189553</pub-id>, PMID: <pub-id pub-id-type="pmid">37396166</pub-id></citation></ref>
<ref id="ref21"><label>21.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname> <given-names>J</given-names></name> <name><surname>Yang</surname> <given-names>J</given-names></name> <name><surname>Chen</surname> <given-names>Y</given-names></name> <name><surname>Rui</surname> <given-names>J</given-names></name> <name><surname>Xu</surname> <given-names>M</given-names></name> <name><surname>Chen</surname> <given-names>M</given-names></name></person-group>. <article-title>Association of METS-IR index with prevalence of gallbladder stones and the age at the first gallbladder stone surgery in US adults: a cross-sectional study</article-title>. <source>Front Endocrinol</source>. (<year>2022</year>) <volume>13</volume>:<fpage>1025854</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fendo.2022.1025854</pub-id>, PMID: <pub-id pub-id-type="pmid">36263324</pub-id></citation></ref>
<ref id="ref22"><label>22.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ghorbani</surname> <given-names>M</given-names></name> <name><surname>Hekmatdoost</surname> <given-names>A</given-names></name> <name><surname>Darabi</surname> <given-names>Z</given-names></name> <name><surname>Sadeghi</surname> <given-names>A</given-names></name> <name><surname>Yari</surname> <given-names>Z</given-names></name></person-group>. <article-title>Dietary inflammatory index and risk of gallstone disease in Iranian women: a case-control study</article-title>. <source>BMC Gastroenterol</source>. (<year>2023</year>) <volume>23</volume>:<fpage>311</fpage>. doi: <pub-id pub-id-type="doi">10.1186/s12876-023-02943-9</pub-id>, PMID: <pub-id pub-id-type="pmid">37710148</pub-id></citation></ref>
<ref id="ref23"><label>23.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hsing</surname> <given-names>AW</given-names></name> <name><surname>Sakoda</surname> <given-names>LC</given-names></name> <name><surname>Rashid</surname> <given-names>A</given-names></name> <name><surname>Andreotti</surname> <given-names>G</given-names></name> <name><surname>Chen</surname> <given-names>J</given-names></name> <name><surname>Wang</surname> <given-names>BS</given-names></name> <etal/></person-group>. <article-title>Variants in inflammation genes and the risk of biliary tract cancers and stones: a population-based study in China</article-title>. <source>Cancer Res</source>. (<year>2008</year>) <volume>68</volume>:<fpage>6442</fpage>&#x2013;<lpage>52</lpage>. doi: <pub-id pub-id-type="doi">10.1158/0008-5472.Can-08-0444</pub-id>, PMID: <pub-id pub-id-type="pmid">18676870</pub-id></citation></ref>
<ref id="ref24"><label>24.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kehagias</surname> <given-names>I</given-names></name> <name><surname>Bellou</surname> <given-names>A</given-names></name> <name><surname>Kehagias</surname> <given-names>D</given-names></name> <name><surname>Markopoulos</surname> <given-names>G</given-names></name> <name><surname>Amanatidis</surname> <given-names>T</given-names></name> <name><surname>Alexandrou</surname> <given-names>A</given-names></name> <etal/></person-group>. <article-title>Long-term (11&#x202F;+&#x202F;years) efficacy of sleeve gastrectomy as a stand-alone bariatric procedure: a single-center retrospective observational study</article-title>. <source>Langenbeck's Arch Surg</source>. (<year>2022</year>) <volume>408</volume>:<fpage>4</fpage>. doi: <pub-id pub-id-type="doi">10.1007/s00423-022-02734-y</pub-id>, PMID: <pub-id pub-id-type="pmid">36577828</pub-id></citation></ref>
<ref id="ref25"><label>25.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname> <given-names>T</given-names></name> <name><surname>Wang</surname> <given-names>W</given-names></name> <name><surname>Ji</surname> <given-names>Y</given-names></name> <name><surname>Wang</surname> <given-names>Y</given-names></name> <name><surname>Liu</surname> <given-names>X</given-names></name> <name><surname>Cao</surname> <given-names>L</given-names></name> <etal/></person-group>. <article-title>Association between different combination of measures for obesity and new-onset gallstone disease</article-title>. <source>PloS One</source>. (<year>2018</year>) <volume>13</volume>:<fpage>e0196457</fpage>. doi: <pub-id pub-id-type="doi">10.1371/journal.pone.0196457</pub-id>, PMID: <pub-id pub-id-type="pmid">29772027</pub-id></citation></ref>
<ref id="ref26"><label>26.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Stender</surname> <given-names>S</given-names></name> <name><surname>Nordestgaard</surname> <given-names>BG</given-names></name> <name><surname>Tybjaerg-Hansen</surname> <given-names>A</given-names></name></person-group>. <article-title>Elevated body mass index as a causal risk factor for symptomatic gallstone disease: a Mendelian randomization study</article-title>. <source>Hepatology (Baltimore, Md)</source>. (<year>2013</year>) <volume>58</volume>:<fpage>2133</fpage>&#x2013;<lpage>41</lpage>. doi: <pub-id pub-id-type="doi">10.1002/hep.26563</pub-id>, PMID: <pub-id pub-id-type="pmid">23775818</pub-id></citation></ref>
<ref id="ref27"><label>27.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nussbaumerova</surname> <given-names>B</given-names></name> <name><surname>Rosolova</surname> <given-names>H</given-names></name></person-group>. <article-title>Obesity and dyslipidemia</article-title>. <source>Curr Atheroscler Rep</source>. (<year>2023</year>) <volume>25</volume>:<fpage>947</fpage>&#x2013;<lpage>55</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s11883-023-01167-2</pub-id>, PMID: <pub-id pub-id-type="pmid">37979064</pub-id></citation></ref>
<ref id="ref28"><label>28.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Scragg</surname> <given-names>RK</given-names></name> <name><surname>Calvert</surname> <given-names>GD</given-names></name> <name><surname>Oliver</surname> <given-names>JR</given-names></name></person-group>. <article-title>Plasma lipids and insulin in gall stone disease: a case-control study</article-title>. <source>Br Med J (Clin Res Ed)</source>. (<year>1984</year>) <volume>289</volume>:<fpage>521</fpage>&#x2013;<lpage>5</lpage>. doi: <pub-id pub-id-type="doi">10.1136/bmj.289.6444.521</pub-id>, PMID: <pub-id pub-id-type="pmid">6432171</pub-id></citation></ref>
<ref id="ref29"><label>29.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nepokroeff</surname> <given-names>CM</given-names></name> <name><surname>Lakshmanan</surname> <given-names>MR</given-names></name> <name><surname>Ness</surname> <given-names>GC</given-names></name> <name><surname>Dugan</surname> <given-names>RE</given-names></name> <name><surname>Porter</surname> <given-names>JW</given-names></name></person-group>. <article-title>Regulation of the diurnal rhythm of rat liver beta-hydroxy-beta-methylglutaryl coenzmye a reductase activity by insulin, glucagon, cyclic AMP and hydrocortisone</article-title>. <source>Arch Biochem Biophys</source>. (<year>1974</year>) <volume>160</volume>:<fpage>387</fpage>&#x2013;<lpage>93</lpage>. doi: <pub-id pub-id-type="doi">10.1016/0003-9861(74)90412-3</pub-id>, PMID: <pub-id pub-id-type="pmid">4364764</pub-id></citation></ref>
<ref id="ref30"><label>30.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Maurer</surname> <given-names>KJ</given-names></name> <name><surname>Rao</surname> <given-names>VP</given-names></name> <name><surname>Ge</surname> <given-names>Z</given-names></name> <name><surname>Rogers</surname> <given-names>AB</given-names></name> <name><surname>Oura</surname> <given-names>TJ</given-names></name> <name><surname>Carey</surname> <given-names>MC</given-names></name> <etal/></person-group>. <article-title>T-cell function is critical for murine cholesterol gallstone formation</article-title>. <source>Gastroenterology</source>. (<year>2007</year>) <volume>133</volume>:<fpage>1304</fpage>&#x2013;<lpage>15</lpage>. doi: <pub-id pub-id-type="doi">10.1053/j.gastro.2007.07.005</pub-id>, PMID: <pub-id pub-id-type="pmid">17919501</pub-id></citation></ref>
<ref id="ref31"><label>31.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mu&#x00F1;oz</surname> <given-names>LE</given-names></name> <name><surname>Boeltz</surname> <given-names>S</given-names></name> <name><surname>Bilyy</surname> <given-names>R</given-names></name> <name><surname>Schauer</surname> <given-names>C</given-names></name> <name><surname>Mahajan</surname> <given-names>A</given-names></name> <name><surname>Widulin</surname> <given-names>N</given-names></name> <etal/></person-group>. <article-title>Neutrophil extracellular traps initiate gallstone formation</article-title>. <source>Immunity</source>. (<year>2019</year>) <volume>51</volume>:<fpage>443</fpage>&#x2013;<lpage>50.e4</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.immuni.2019.07.002</pub-id>, PMID: <pub-id pub-id-type="pmid">31422870</pub-id></citation></ref>
<ref id="ref32"><label>32.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Molloy</surname> <given-names>EJ</given-names></name> <name><surname>O'Neill</surname> <given-names>AJ</given-names></name> <name><surname>Grantham</surname> <given-names>JJ</given-names></name> <name><surname>Sheridan-Pereira</surname> <given-names>M</given-names></name> <name><surname>Fitzpatrick</surname> <given-names>JM</given-names></name> <name><surname>Webb</surname> <given-names>DW</given-names></name> <etal/></person-group>. <article-title>Sex-specific alterations in neutrophil apoptosis: the role of estradiol and progesterone</article-title>. <source>Blood</source>. (<year>2003</year>) <volume>102</volume>:<fpage>2653</fpage>&#x2013;<lpage>9</lpage>. doi: <pub-id pub-id-type="doi">10.1182/blood-2003-02-0649</pub-id>, PMID: <pub-id pub-id-type="pmid">12791649</pub-id></citation></ref>
<ref id="ref33"><label>33.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chung</surname> <given-names>HH</given-names></name> <name><surname>Or</surname> <given-names>YZ</given-names></name> <name><surname>Shrestha</surname> <given-names>S</given-names></name> <name><surname>Loh</surname> <given-names>JT</given-names></name> <name><surname>Lim</surname> <given-names>CL</given-names></name> <name><surname>Ong</surname> <given-names>Z</given-names></name> <etal/></person-group>. <article-title>Estrogen reprograms the activity of neutrophils to foster protumoral microenvironment during mammary involution</article-title>. <source>Sci Rep</source>. (<year>2017</year>) <volume>7</volume>:<fpage>46485</fpage>. doi: <pub-id pub-id-type="doi">10.1038/srep46485</pub-id>, PMID: <pub-id pub-id-type="pmid">28429725</pub-id></citation></ref>
</ref-list>
</back>
</article>